Unassociated Document
 
Registration No. _____________________________
 
As filed with the Securities and Exchange Commission on May 1, 2006
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington D.C. 20549
 

 
FORM S-8
 
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
BOVIE MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
 
No. 11-2644611
(State or other jurisdication of Incorporation or Organization
(IRS - Employer Identification No.)
 

 
734 Walt Whitman Rd.,
Melville, New York 11747
(516) 421-5452
 
(Address, including zip code, and telephone number,
including area code, or registrant's principal executive offices)
 
BOVIE MEDICAL CORPORATION
2003 KEY SERVICES STOCK OPTION PLAN
 
(Full title of plan)
 
Andrew Makrides
President
Bovie Medical Corporation
734 Walt Whitman Road
Melville, NY 11747
(Name and address, including zip code, and telephone
number, including area code, of agent for service)
 
Copies to:
Alfred V. Greco, Esq.
SIERCHIO GRECO & GRECO, LLP
720 Fifth Avenue, Suite 1301
New York, New York 10019
Tel: 212-246-3030
Fax: 212-246-2225

(Registration Statement cover page continued) 
 

 
CALCULATION OF REGISTRATION FEE
 
 
 
 
 
Proposed
 
Proposed
 
 
 
 
 
 
 
Maximum
 
Maximum
 
 
 
Title of Each
     
Offering
 
Aggregate
 
Amount of
 
Class of  
 
Amount to be  
 
Price Per
 
Offering
 
Registration 
 
Be registered 
 
Registered (1) 
 
Share (1)
 
Price (1)
 
Fee 
 
                   
Common Stock, Par value $.001 per share (2)
   
500,000
 
$
6.50
 
$
3,500,000
 
$
99.78
 

(1)
Estimated solely for the purpose of calculating the registration fee.

(2)
The shares registered pursuant to this Registration Statement are available for grant as of the date of this Registration Statement under the registrant’s 2003 Key Services Stock Option Plan and available for issuance pursuant to certain stock options the forms of which are attached as exhibits to this Registration Statement.

(3)
Pursuant to General Instruction E, the registration fee paid in connection herewith is based on the maximum aggregate price at which securities covered by this registration statement are proposed to be offered.
 
STATEMENT

The purpose of this filing is to add 500,000 additional shares of common stock of Bovie Medical Corporation to be covered by our Form S-8 Registration Statement Number 333-134060, originally filed with the Securities and Exchange Commission on May 12, 2006, the contents of which are incorporated herein by reference.


 
SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the town of Melville, New York, on this 13th day of December, 2007.
 
Bovie Medical Corporation
By /S/ Andrew Makrides
Andrew Makrides, Principal Executive Officer
 
Pursuant to the requirements of the Securities Act of 1933, this Registration statement has been signed by the following persons in the capacities and on the dates indicated.
 
Signature
 
Capacity in Which Signed
 
Date
         
/S/ Andrew Makrides
 
President, Director,
 
November 15, 2007
Andrew Makrides
 
Principal Executive Officer
   
         
/S/ Gary Picket
 
Chief Financial Officer and
 
November 15, 2007
Gary Pickett
 
Principal Accounting Officer
   
         
 
       
Robert J. Saron
 
Director
 
November __, 2007
         
/S/ George Kromer
       
George Kromer
 
Director
 
November 15, 2007
         
/S/ Brian Madden
       
Brian Madden
 
Director
 
November 16, 2007
         
/S/ Michael Norman
       
Michael Norman
 
Director
 
November 15, 2007
         
/S/ Randy Rossi
       
Randy D. Rossi
 
Director
 
November 19, 2007
         
 
       
August Lentricchia
 
Director
 
November __, 2007
 
EXHIBIT INDEX

Sequentially Document
Numbered Page
 
Description of Document
     
5.1
 
Opinion of Sierchio Greco & Greco, LLP
     
23.1
 
Consent of Sierchio Greco & Greco, LLP
   
(contained in opinion)
     
23.2
 
Consent of Bloom & Company